Skip to main content
OpenTrials

Clinical trial condition

Bacterial Infections and Mycoses

Explore clinical trials studying Bacterial Infections and Mycoses. Study availability and eligibility vary by location and protocol.

5,892 public trials 632 recruiting studies
Refine in advanced search Browse all conditions

Bacterial Infections and Mycoses trial results

Completed

Scandinavian Cystic Fibrosis Azithromycin Study

NCT00411736

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • CF-centre Skejby, Skejby Sygehus, Brendstrupgaardsvej 100 Aarhus N, Denmark
  • CF-centre Copenhagen, Rigshospitalet, Blegdamsvej 9 Copenhagen, Denmark
  • CF-centre Bergen, Haukeland Universitetssykehus Bergen, Norway
  • CF-centre Oslo, Ullevaal Universitetssykehus Oslo, Norway
View Trial Details
Completed

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

NCT01466387

Conditions
Arbovirus Infections, Bacterial Infections, Bacterial Infections and Mycoses, +37 more
Locations
  • Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II Bratri Stefanu 895, Hradec Kralove, Czechia
  • Bernhard Nocht Strasse 74, Free and Hanseatic City of Hamburg, Germany
  • Berliner Centrum Fur Reise und Tropenmedizin Jaegerstrasse 67-69, State of Berlin, Germany
  • University of Munich Georgenstr.5 München, Germany
View Trial Details
Completed

Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection

NCT01059565

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Burkholderia Infections, +10 more
Locations
  • Mobile, Alabama, United States
  • Phoenix, Arizona, United States
  • Little Rock, Arkansas, United States
  • Denver, Colorado, United States
View all 35 locations
View Trial Details
Completed

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS-404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

NCT02066428

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +4 more
Locations
  • Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm County, Sweden
View Trial Details

Related conditions